Robin Elliott

Amgen (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index17.5kcitations16works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone Metabolism and Diseases(9), Bone health and treatments(7), NF-κB Signaling Pathways(5), Ion channel regulation and function(3), Ion Channels and Receptors(3)

Publications16 total

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
Frontiers in Pharmacology·2019· 132 citedOpen Access
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide are Potent TMEM16A Antagonists that Fully Bronchodilate Airways
2018· 9 citedOpen Access
Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3
Journal of Medicinal Chemistry·2015· 46 citedOpen Access
Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease
Journal of Pharmacology and Experimental Therapeutics·2013· 67 cited
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL
Journal of Bone and Mineral Research·2008· 429 cited
197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo
European Journal of Cancer Supplements·2006· 14 cited
The Osteoclast Differentiation Factor Osteoprotegerin-Ligand Is Essential for Mammary Gland Development
Cell·2000· 747 citedOpen Access
Taci Is a Traf-Interacting Receptor for Tall-1, a Tumor Necrosis Factor Family Member Involved in B Cell Regulation
The Journal of Experimental Medicine·2000· 248 citedOpen Access
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
Proceedings of the National Academy of Sciences·2000· 1.1k citedOpen Access
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Nature·1999· 288 citedOpen Access
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Nature·1999· 1.9k cited
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
Proceedings of the National Academy of Sciences·1999· 1.6k citedOpen Access
Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
Cell·1998· 5.4k citedOpen Access
ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5
Journal of Biological Chemistry·1997· 178 citedOpen Access
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
Cell·1997· 5.1k citedOpen Access
B61 is a ligand for the ECK receptor protein-tyrosine kinase
Nature·1994· 242 cited

Frequent Co-authors

William J. Boyle(9), Anne Colombero(8), John K. Sullivan(7), David L. Lacey(6), Gwyneth Van(5), Sean Morony(5), Susan McCabe(5), Hong‐Lin Tan(4), Colin R. Dunstan(4), Sheila Scully(4), Nessa Hawkins(4), Michael J. Kelley(4), Casey Capparelli(4), Hailing Hsu(4), Xing-Zhong Xia(4), Kevin Gaida(4), Ildiko Sarosi(3), Hung Q. Nguyen(3), Young‐Yun Kong(3), Josef Penninger(3)